Cardiovascular Medical Lasers Market Report 2026

Cardiovascular Medical Lasers Market Overview

• Cardiovascular Medical Lasers market size has reached to $0.44 billion in 2025 • Expected to grow to $2.31 billion in 2030 at a compound annual growth rate (CAGR) of 38.7% • Growth Driver: Rising Cardiovascular Diseases Drive Demand For Cardiovascular Medical Lasers • Market Trend: Cardiovascular Medical Laser Companies Focus On Non-Invasive Technologies • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Cardiovascular Medical Lasers Market?

Cardiovascular medical lasers are used in the treatment of medical conditions related to the heart. These lasers are commonly used during transmyocardial laser revascularization. The cardiovascular medical lasers market covered in this report is segmented by type into excimer lasers and carbon dioxide laser. The carbon dioxide laser aids in the removal of thin layers of skin while causing minimal damage to surrounding structures. These are used in various applications such as laser vascular anastomosis, transmyocardial laser revascularization, and laser angioplasty for peripheral arterial diseases that are used by end users such as hospitals, specialty clinics, and ambulatory surgery centers.

What Is The Cardiovascular Medical Lasers Market Growth Forecast?

The cardiovascular medical lasers market size is expected to see exponential growth in the next few years. It will grow to $2.31 billion in 2030 at a compound annual growth rate (CAGR) of 38.7%. The growth in the forecast period can be attributed to increasing demand for advanced cardiovascular treatments, rising investments in precision cardiac care, growing adoption of laser-assisted surgical procedures, expansion of specialty cardiac hospitals, continuous innovation in medical laser systems. Major trends in the forecast period include increasing adoption of laser-based revascularization procedures, rising use of minimally invasive cardiac laser therapies, growing precision in laser vascular applications, expansion of advanced excimer and co2 laser platforms, enhanced focus on procedure safety and accuracy.

Global Cardiovascular Medical Lasers Market Segmentation

1) By Type: Excimer Laser, Carbon Dioxide Laser 2) By Application: Laser Vascular Anastomosis, Transmyocardial Laser Revascularization, Laser Angioplasty For Peripheral Arterial Diseases 3) By End Use: Hospitals, Specialty Clinics, Ambulatory Surgery Centers Subsegments: 1) By Excimer Laser: Ultraviolet Excimer Lasers, Pulsed Excimer Lasers, Other Excimer Lasers 2) By Carbon Dioxide Laser: Continuous Wave CO2 Lasers, Pulsed CO2 Lasers, Super Pulsed CO2 Lasers, Other Carbon Dioxide Lasers

What Is The Driver Of The Cardiovascular Medical Lasers Market?

The rising incidence of cardiovascular diseases is expected to propel the growth of the cardiovascular medical lasers market going forward. Cardiovascular diseases refer to a group of disorders affecting the heart and blood vessels, including conditions such as coronary artery disease, heart failure, and stroke. The rise in cardiovascular diseases can be attributed to unhealthy eating habits, where excessive consumption of processed foods and fats leads to higher cholesterol levels, increasing heart risks. Cardiovascular medical lasers aid in cardiovascular diseases management by offering precise, minimally invasive treatment options that improve blood flow and remove blockages with greater accuracy. They reduce surgical trauma through targeted laser applications, enhancing patient recovery and overall cardiovascular care. For instance, in October 2024, according to the Centers for Disease Control, a US-based government agency, in 2023, approximately 919,032 people died from cardiovascular disease, accounting for 1 in every 3 deaths. Therefore, the rising incidence of cardiovascular diseases is driving the growth of the cardiovascular medical lasers industry.

Key Players In The Global Cardiovascular Medical Lasers Market

Major companies operating in the cardiovascular medical lasers market are Boston Scientific Corporation, Cardiovascular Systems Inc., AngioDynamics Inc., RA Medical Systems Inc., DEKA Research & Development Corporation, EUFOTON S.P.A., Fotona d.d., Gigaa Laser Group, IRIDEX Corporation, Lumenis Ltd., PhotoMedex Inc., Quanta System S.p.A., Vascular Solutions Inc., Spectranetics Corporation, CardioGenesis Corporation, El.En. Group, Asclepion Laser Technologies GmbH, Dornier MedTech GmbH, Laser Engineering Applications (LEA), Biolitec AG

Global Cardiovascular Medical Lasers Market Trends and Insights

Major companies operating in the cardiovascular medical laser market are focused on developing non-invasive technologies such as specialized lasers to enhance treatment efficacy and patient safety. These innovations aim to improve outcomes for conditions such as atherosclerosis and varicose veins. A specialized laser is engineered for targeted uses, optimizing characteristics such as wavelength and output power. These lasers are commonly employed in fields like medicine, manufacturing, and telecommunications.For instance, in May 2024., Aster Medcity, a India-based Kerala's first quaternary care hospital, Excimer laser angioplasty is a minimally invasive procedure used to treat complex cardiovascular conditions by modifying and removing arterial plaque. Its advantages include higher success rates, reduced tissue damage, and shorter recovery times.

What Are Latest Mergers And Acquisitions In The Cardiovascular Medical Lasers Market?

In August 2024, JC Medical Inc., a US-based medical equipment supplier, acquired Edwards Lifesciences for an undisclosed amount. This acquisition strengthens JC Medical’s position in the structural-heart market by leveraging Edwards Lifesciences’ advanced heart-valve technologies to support development of its J-Valve system for treating severe symptomatic native aortic regurgitation. It further enhances JC Medical’s product-development capabilities and global reach by integrating Edwards’ resources, expertise, and innovation ecosystem. Edwards Lifesciences is a US-based medical technology company focused on innovative heart-valve therapies and cardiovascular technologies.

Regional Outlook

North America was the largest region in the cardiovascular medical lasers market in 2025. Asia-Pacific was the second-largest region in the global cardiovascular medical lasers market report. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are China, India, Japan, Australia, Indonesia, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, Taiwan, New Zealand, UK, Germany, France, Italy, Spain, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.

What Defines the Cardiovascular Medical Lasers Market?

The cardiovascular medical lasers market consists of sales of instruments such as excimer lasers and carbon dioxide lasers. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.